News in brief: Creating the future of medicine at UVA

Header envision esser contr
Sheybani in lab
Biomedical Engineering

Natasha Sheybani speaks at U Ask, UVA Answers

Video

Natasha Sheybani, UVA assistant professor of biomedical engineering and research director of the Focused Ultrasound Immuno-Oncology Center, joins U Ask, UVA Answers at Crozet Library on November 18th at 6pm. She’ll discuss how focused ultrasound, a noninvasive technology harnessing therapeutic sound waves and the immune system, could address major challenges in breast cancer treatment.

MPs of the microplastics study
Medicine

New Multidisciplinary Study Investigates Microplastics in the Breast Milk Feeding Pathway in Hospitalized Newborns

A UVA multidisciplinary team is launching a pilot study to measure microplastic exposure in NICU infants fed expressed breast milk through plastic medical devices. Combining engineering, nursing, and neonatology expertise, researchers will examine each stage of milk handling to identify contamination sources and develop strategies to reduce exposure for hospitalized newborns and families at home.

Image of Kelly Hochstetler
Announcement

UVA’s Kelly Hochstetler Named to COGR Board of Directors 

Kelly Hochstetler, UVA’s associate vice president for research compliance and regulatory affairs, has joined the Council on Governmental Relations Board of Directors for a three-year term. COGR represents over 230 research institutions on federal policy issues, giving Hochstetler direct input into regulations shaping research administration, compliance and intellectual property nationwide while continuing her work supporting UVA’s research community.

International

UVA, INSERM Explore International Research Collaboration

The University of Virginia and INSERM, France’s National Institute of Health and Medical Research, brought together researchers from both institutions for a virtual matchmaking symposium designed to accelerate international scientific collaboration and lay the foundation for future joint research initiatives.

The half-day event connected investigators across multiple disciplines, creating opportunities to identify shared scientific interests, exchange ideas, and explore collaborative projects that could advance discoveries in human health.

Lu-Q.-Le-1200x800
Medicine

Study Identifies Stem Cells and Signaling Pathways Critical for Healthy, Hydrated Skin

Researchers led by Lu Q. Le, MD, PhD, have identified KROX20-marked stem cells and the Notch signaling pathway as essential regulators of sebaceous gland development and sebum production. Published in the Journal of Clinical Investigation, the study shows a topical Notch-activating drug restored gland structure and reduced water loss, offering a potential treatment for age-related dry skin.

New Senators on the Hill
Democracy

The Conversation: Democrats’ agenda will be set by their ability to organize and compromise — not by the socialist, progressive or centrist factions all claiming victory

A historic Democratic midterm sweep has produced an ideologically diverse 120th Congress, split between progressives, moderates, and establishment figures all claiming credit. Political scientist SoRelle Wyckoff Gaynor examines how large majorities, leadership elections, and competing policy visions on healthcare and corruption will shape whether this fractious coalition can govern effectively together.

Psjdbwovcwpktvlgvokukjsaogticitnen2pvp2c
Medicine

New Blood Test Claiming To Detect 50‑Plus Cancers May Not Be That Useful

The Galleri blood test, which screens for 50-plus cancers via a single draw, recently gained FDA advisory panel recommendation despite missing 69% of cancers overall and showing no proven ability to reduce late-stage diagnoses or cancer deaths. A physician examines the evidence, urging caution and continued use of standard screenings alongside this promising but unproven technology.

Lukens and Walsh in lab
Neuroscience

Alzheimer’s Discovery Reveals Brain Cleaning Gone Wrong

UVA Health researchers have discovered that the CASS4 gene plays a crucial role in Alzheimer’s disease by directing microglia, the brain’s cleaning cells, to contain amyloid-beta plaques. When CASS4 malfunctions, plaques grow faster and spread aggressively, suggesting the gene could serve as a biomarker and therapeutic target for treating or preventing Alzheimer’s.

Hand holding vial of blood
Cancer

The Conversation: New blood test claims to detect 50‑plus cancers before symptoms – but there’s no evidence it can reduce your risk of dying from cancer

The Galleri blood test, recently recommended for FDA approval, claims to detect over 50 cancers from a single blood draw. Despite its low false positive rate and high positive predictive value, clinical trials show it misses nearly 70% of cancers and hasn’t proven to reduce late-stage diagnoses or cancer deaths, raising concerns among experts.